Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lazzarin

Showing results (61-70 of 384) with videos related to

Pageof 39
Sort By:
Journal of Acquired Immune Deficiency Syndromes|January 1, 1993
Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudineL Vago, A Castagna, A Lazzarin, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Virological patterns of hepatitis C virus in chronic hepatitis C with biochemical sustained response to interferon therapyM S De Mitri, T Iervese, E Pisi, et al.
The Journal of Infectious Diseases|April 1, 1991
HLA-B35 and thrombocytopenia in drug users with AIDSN Eisera, G Fabio, M Marchini, et al.
The Journal of Trauma|September 1, 1983
Preliminary clinical experiences with the use of immunomodulators in burnsL Donati, A Lazzarin, M Signorini, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary resultsM Galli, P Crocchiolo, C Negri, et al.
Journal of Biological Regulators and Homeostatic Agents|May 11, 2002
HIV-1 DNA and RNA kinetics in primary HIV infectionF Lillo, M Grasso, S Lodini, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with AIDS-related tumors and chemotherapy-induced bone-marrow suppressionU Tirelli, R Sorio, S Monfardini, et al.
AIDS (London, England)|September 14, 2000
Metabolic disorders in a cohort of patients treated with highly aggressive antiretroviral therapies during primary HIV-1 infectionB Capiluppi, D Ciuffreda, M Sciandra, et al.
Journal of Biological Regulators and Homeostatic Agents|November 24, 1999
The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogsN Gianotti, F Moretti, G Tambussi, et al.
The New Microbiologica|January 14, 2005
The introduction of the fusion inhibitors in the HAART-regimensH Hasson, A Castagna, M Clementi, et al.
Pageof 39

Showing results (61-70 of 384) with videos related to

Sort By:
Pageof 39
Journal of Acquired Immune Deficiency Syndromes|January 1, 1993
Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudineL Vago, A Castagna, A Lazzarin, et al.
Hepatology (Baltimore, Md.)|May 1, 1996
Virological patterns of hepatitis C virus in chronic hepatitis C with biochemical sustained response to interferon therapyM S De Mitri, T Iervese, E Pisi, et al.
The Journal of Infectious Diseases|April 1, 1991
HLA-B35 and thrombocytopenia in drug users with AIDSN Eisera, G Fabio, M Marchini, et al.
The Journal of Trauma|September 1, 1983
Preliminary clinical experiences with the use of immunomodulators in burnsL Donati, A Lazzarin, M Signorini, et al.
Drugs Under Experimental and Clinical Research|January 1, 1985
Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary resultsM Galli, P Crocchiolo, C Negri, et al.
Journal of Biological Regulators and Homeostatic Agents|May 11, 2002
HIV-1 DNA and RNA kinetics in primary HIV infectionF Lillo, M Grasso, S Lodini, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with AIDS-related tumors and chemotherapy-induced bone-marrow suppressionU Tirelli, R Sorio, S Monfardini, et al.
AIDS (London, England)|September 14, 2000
Metabolic disorders in a cohort of patients treated with highly aggressive antiretroviral therapies during primary HIV-1 infectionB Capiluppi, D Ciuffreda, M Sciandra, et al.
Journal of Biological Regulators and Homeostatic Agents|November 24, 1999
The rationale for a study on HIV-1 reverse transcriptase mutations and outcome of antiretroviral therapy with two nucleoside analogsN Gianotti, F Moretti, G Tambussi, et al.
The New Microbiologica|January 14, 2005
The introduction of the fusion inhibitors in the HAART-regimensH Hasson, A Castagna, M Clementi, et al.
Pageof 39